Transcript
Page 1: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30

Challenging Bilateral Iliac Occlusions

Mr. Hany Zayed MD, MSc, FRCS

Consultant Vascular Surgeon

Guy’s and St. Thomas’ NHS Foundation Trust

Page 2: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30

Disclosure

Speaker name:

.................................................................................

I have the following potential conflicts of interest to report:

Consulting

Employment in industry

Stockholder of a healthcare company

Owner of a healthcare company

✓ Other(s)

I do not have any potential conflict of interest

Page 3: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 4: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 5: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 6: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 7: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 8: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 9: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 10: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 11: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 12: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30

• 74 Yrs

• Cardiovascular Risk Factors:

IHD, Coronary stenting

Pacemaker

HTN

Hyperchol.

• Life-limiting Intermittent Claudication:

Sole carer of Wheelchair-bound wife.

• Best medical treatment

• Completed SET

Page 13: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 14: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30

Revascularisation Plan

• Right Femoral endarterectomy + Access

• Left Brachial Percutaneous Access:

Imaging

Antegrade recanalisation if Retrograde approach fails

• Left Femoral Percutaneous Access

Page 15: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 16: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 17: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 18: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 19: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 20: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 21: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 22: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30

Which Covered-Stent to use ?

Page 23: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 24: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 25: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30
Page 26: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30

Conclusion

• VBX is a useful addition to the endovascular armamentarium.

• Potential solution to challenging Aorto-Iliac occlusive disease.

Page 27: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30

Thank You

Page 28: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30

Challenging Bilateral Iliac Occlusions

Mr. Hany Zayed MD, MSc, FRCS

Consultant Vascular Surgeon

Guy’s and St. Thomas’ NHS Foundation Trust


Top Related